Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Daxor Corporation (DXR) vs Milestone Scientific, Inc. (MLSS)

Daxor Corporation and Milestone Scientific, Inc. are both Medical Instruments & Supplies companies. Daxor Corporation is the larger, with a market value of $66.5M against $37.2M — 1.8× the size. Milestone Scientific, Inc. has negative trailing earnings, so its P/E is not meaningful; Daxor Corporation trades at 5.1×. Milestone Scientific, Inc. grew revenue faster over the last twelve months: 3.72% against −52.1%. Milestone Scientific, Inc. has the higher net margin (−44.0% vs −251.9%) and the lower return on invested capital (−136.2% vs 0.00%). Across the 17 metrics below, Daxor Corporation leads on 11 and Milestone Scientific, Inc. on 6.

Valuation

Metric DXR MLSS Medical Instruments & Supplies median
P/E 5.12 n/m 34.17
P/S n/m 4.05 2.83
P/B 1.62 11.00 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales (15.67) 3.88 3.06
Earnings yield 19.53% (10.73%) (1.84%)
Free cash flow yield (15.30%) (2.24%) 0.17%

Profitability

Metric DXR MLSS Medical Instruments & Supplies median
Gross margin 0.00% 70.23% 54.62%
Operating margin 0.00% (43.56%) 1.64%
Net margin (251.91%) (43.98%) 0.00%
Free cash flow margin 224.51% (6.98%) 1.61%
Return on equity 37.62% (121.68%) 0.00%
Return on assets 35.90% (50.54%) 0.00%
Return on invested capital 0.00% (136.16%) 0.00%

Growth

Metric DXR MLSS Medical Instruments & Supplies median
Revenue growth (TTM) (52.06%) 3.72% 9.20%
EPS growth (last fiscal year) 7.63% (16.67%) —
Revenue growth, 5-year CAGR 0.00% 10.54% 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DXR MLSS Medical Instruments & Supplies median
Debt to equity 0.00 0.14 0.08
Current ratio 1.66 1.85 2.49
Net debt to EBITDA 0.00 0.05 0.83

Dividend

Metric DXR MLSS Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric DXR MLSS Medical Instruments & Supplies median
Market cap 66.52m 37.23m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack